U-104,
U-104,
178606-66-1,
4-(3-(4-fluorophenyl)ureido)benzenesulfonamide,
1-(4-fluorophenyl)-3-(4-sulfamoylphenyl)urea,
mst-104,
NSC213841,
CHEMBL1615281,
4-{[(4-Fluorophenyl)carbamoyl]amino}benzenesulfonamide,
4-{[(4'-Fluorophenyl)Carbamoyl]Amino}Benzenesulfonamide,
4-[[[(4-Fluorophenyl)amino]carbonyl]amino]-benzenesulfonamide,
4-[3-(4-Fluorophenyl)ureido]benzenesulfonamide,
WWZ,
3n4b,
AC1L7H1Z,
SCHEMBL672955,
GTPL10149,
AOB5732,
EX-A904,
SLC0111,
YJQZNWPYLCNRLP-UHFFFAOYSA-N,
HMS3651H21,
SLC-0111,
ZINC1752601,
BDBM50334354,
MFCD00159265,
s2866,
4-fluorophenylureido-benzenesulfonamide,
AKOS001123930,
compound 7 [PMID: 21361354],
CS-4495,
MCULE-4710078413,
NSC 213841,
NSC-213841,
SB19580,
NCGC00379154-03,
AK341046,
BC600778,
HY-13513,
FT-0699833,
SW220124-1,
U 104,
U-104, >=98% (HPLC),
U-104;NSC213841;MST104,
X5935,
A14959,
Carbonic Anhydrase IX/XII Inhibitor II(U-104),
J-690246,
(3?,5?)-3,14,17-Trihydroxycard-20(22)-enolide,
4-(((4-Fluoroanilino)carbonyl)amino)benzenesulfonamide,
4-{[(4''-Fluorophenyl)carbamoyl]amino}benzenesulfonamide,
4-[[[(4-Fluorophenyl)amino]carbonyl]amino]-benzesulfonamide,
C13H12FN3O3S,
CID310360,
RW3516,
U104,
A4358,